Abstract:All forms of diabetes mellitus involve the loss or dysfunction of pancreatic beta cells, with the former predominating in type 1 diabetes and the latter in type 2 diabetes. Deeper understanding of the coupling mechanisms that link glucose metabolism in these cells to the control of insulin secretion is therefore likely to be essential to develop new therapies. Beta cells display a remarkable metabolic specialisation, expressing high levels of metabolic sensing enzymes, including the glucose transporter GLUT2 (encoded by SLC2A2) and glucokinase (encoded by GCK). Genetic evidence flowing from both monogenic forms of diabetes and genome-wide association studies for the more common type 2 diabetes, supports the importance for normal glucose-stimulated insulin secretion of metabolic signalling via altered ATP generation, while also highlighting unsuspected roles for Zn2+ storage, intracellular lipid transfer and other processes. Intriguingly, genes involved in non-oxidative metabolic fates of the sugar, such as those for lactate dehydrogenase (LDHA) and monocarboxylate transporter-1 ([MCT-1] SLC16A1), as well as the acyl-CoA thioesterase (ACOT7) and others, are selectively repressed ('disallowed') in beta cells. Furthermore, mutations in genes critical for mitochondrial oxidative metabolism, such as TRL-CAG1-7 encoding tRNALeu, are linked to maternally inherited forms of diabetes. Correspondingly, impaired Ca2+ uptake into mitochondria, or collapse of a normally interconnected mitochondrial network, are associated with defective insulin secretion. Here, we suggest that altered mitochondrial metabolism may also impair beta cell-beta cell communication. Thus, we argue that defective oxidative glucose metabolism is central to beta cell failure in diabetes, acting both at the level of single beta cells and potentially across the whole islet to impair insulin secretion. Graphical abstract.

β‐Cell failure in diabetes: Common susceptibility and mechanisms shared between type 1 and type 2 diabetes

Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure

Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes

Fallimento β-cellulare nel diabete mellito di tipo 1 e di tipo 2: esistono meccanismi comuni?

Untangling the genetics of beta cell dysfunction and death in type 1 diabetes

Pathomechanisms of Type 2 Diabetes Genes

Pancreatic -cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes

From Clinical Suspicion to Genetic Diagnosis and Management of Rare Types of Diabetes

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Metabolic and functional specialisations of the pancreatic beta cell: gene disallowance, mitochondrial metabolism and intercellular connectivity

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Β-Cell Neogenesis: A Rising Star to Rescue Diabetes Mellitus.

Molecular Mechanisms in Autoimmune Type 1 Diabetes: a Critical Review

[Nature History and Genetics of Type 2 Diabetes].

Inside the β Cell: Molecular Stress Response Pathways in Diabetes Pathogenesis

Understanding Type 1 Diabetes: Etiology and Models

Genetics of type 2 diabetes: insight from targeted mouse mutants

Type 1 diabetes: pathogenesis and prevention